Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.
By Jordi Bruix1 , 2, M. Sherman, J. Llovet, M. Beaugrand, Riccardo Lencioni, Andrew K. Burroughs, E. Christensen, L. Pagliaro, M. Colombo, J. Rodés. Journal of Hepatology, 2001
4,137 citations recorded by the source corpus.
Subfields: Epidemiology, Hepatology
View Paper: https://www.semanticscholar.org/paper/890eed1a98f659b972951be9ae493e95b8a4feb9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Jordi Bruix1 , 2
- L. Kulik
- M. Sherman
- Michael M. Abecassis
- Riccardo Lencioni
- M. Kudo
- J. Iredale
- J. Llovet
In Hepatology
- Jordi Bruix1 , 2
- M. Sherman
- Riccardo Lencioni
- L. Kulik
- Michael M. Abecassis
- R. Salem
- M. Kudo
- T. Greten
Citations in the corpus
- Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. (2005, background): “the European Association for the Study of the Liver (21).”
- A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma (2006, methodology): “The diagnosis of HCC was based on the diagnostic criteria for HCC used by the European Association for the Study of the Liver.(17) The diagnosis of HCC was made when 2 radiologic imaging techniques showed typical features of HCC in a patient with an elevated alpha fetoprotein level 400 ng/mL, or in ”